Top Markets
Coin of the day
GeneFerm Biotechnology Co., Ltd. GeneFerm Biotechnology Co., Ltd.

GeneFerm Biotechnology Co., Ltd.

1796
Classement en actions #26677
GeneFerm Biotechnology Co., Ltd. specializes in the development, production,... GeneFerm Biotechnology Co., Ltd. specializes in the development, production, and global distribution of fermented health and wellness products, serving both the Taiwanese domestic market and international clients. The company's extensive product line includes a variety of microbial fermentation offerings such as different types of mushrooms, lactic acid bacteria, other bacterial strains, yeast, and algae. Furthermore, GeneFerm provides a wide array of bio-fermented ingredients, including specialized powders like nattomena, natto fermented powder, red yeast rice fermented powder, and various mycelial powders (e.g., antrodia cinnamomea, cordyceps, reishi, phellinus linteus, armillaria mellea). They also supply beta-glucan powder, fermented fruit and vegetable enzymes, as well as probiotic and peptide components. Beyond its product sales, GeneFerm offers additional services such as private label supplement manufacturing, packaging equipment, and expert microbial fermentation toll manufacturing and consulting. Established in 1988, the company maintains its headquarters in Tainan City, Taiwan.
Prix de l'action
$0.93330147
Capitalisation boursière
$38.69M
Changement (1 jour)
-1.01%
Changement (1 an)
-39.84%
Pays
TW
Échange GeneFerm Biotechnology Co., Ltd. (1796)

Catégorie

Le prix 1796 avec la capitalisation boursière de B
GeneFerm Biotechnology Co., Ltd. GeneFerm Biotechnology Co., Ltd.
1796
$0.93330147
Capitalisation boursière de GeneFerm Biotechnology Co., Ltd.(1796)
Capitalisation boursière: $38.69M
En August 2026, GeneFerm Biotechnology Co., Ltd. a une capitalisation boursière de $38.69M. Cela fait de GeneFerm Biotechnology Co., Ltd. la 26677th entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de GeneFerm Biotechnology Co., Ltd. du 2016 au 2026
1796 par rapport au top 5 des plus populaires stocks
Prix pour 1796 L’actif B La capitalisation boursière de B Résultats
GeneFerm Biotechnology Co., Ltd. GeneFerm Biotechnology Co., Ltd.
$128,004 $38.69M
$5.307T +13,715,068.62%
GeneFerm Biotechnology Co., Ltd. GeneFerm Biotechnology Co., Ltd.
$113,301 $38.69M
$4.697T +12,139,665.34%
GeneFerm Biotechnology Co., Ltd. GeneFerm Biotechnology Co., Ltd.
$100,021 $38.69M
$4.147T +10,716,768.52%
GeneFerm Biotechnology Co., Ltd. GeneFerm Biotechnology Co., Ltd.
$86,436.61 $38.69M
$3.584T +9,261,281.84%
GeneFerm Biotechnology Co., Ltd. GeneFerm Biotechnology Co., Ltd.
$68,366.03 $38.69M
$2.834T +7,325,082.20%